永久免费毛片_亚洲成人看片_亚洲春色另类_亚洲综合免费视频_最新高清无码专区_午夜影院a

Elevation Oncology Acquired After Ending Partnership with CSPC CSPC Elevation Oncology has been acquired by Concentra Biosciences after halting its Claudin18.2 ADC program with CSPC. The deal includes a $22M valuation and future rights tied to EO-1022, its sole remaining HER3-targeted ADC candidate.
mRNA Vaccine Progress Review (January–March) 2025 Market Trend Explore key mRNA vaccine developments from Jan–Mar 2025, covering breakthroughs in cancer, flu, herpes zoster, and tuberculosis prevention and treatment globally.
Over $2 Billion! AstraZeneca Partners with CSPC Pharmaceutical Group AstraZeneca CSPC Pharmaceutical Group (1093.HK) has signed an exclusive licensing agreement with AstraZeneca to globally develop and commercialize CSPC's Lp(a) inhibitor, YS2302018. The deal includes a $100M upfront payment, with potential milestones up to $1.92B plus royalties.

Articles Archives

Hot Articles

All Categories